{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:48:45Z","timestamp":1792273725748,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key Project of Hubei Provincial Administration of Traditional Chinese Medicine","award":["ZY2023Z014"],"award-info":[{"award-number":["ZY2023Z014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10735-026-10908-x","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:42:51Z","timestamp":1786372971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Guanxinshu attenuates atherosclerosis by suppressing Galectin-3-mediated NLRP3 inflammasome activation"],"prefix":"10.1007","volume":"57","author":[{"given":"Ruonan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefang","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gucheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8303-2644","authenticated-orcid":false,"given":"Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"10908_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154490","volume":"246","author":"SIS Al-Hawary","year":"2023","unstructured":"Al-Hawary SIS, Jasim SA, Romero-Parra RM, Bustani GS, Hjazi A, Alghamdi MI et al (2023) NLRP3 inflammasome pathway in atherosclerosis: focusing on the therapeutic potential of non-coding RNAs. Pathol Res Pract 246:154490. https:\/\/doi.org\/10.1016\/j.prp.2023.154490","journal-title":"Pathol Res Pract"},{"key":"10908_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145097","author":"A Arsenijevic","year":"2020","unstructured":"Arsenijevic A, Stojanovic B, Milovanovic J, Arsenijevic D, Arsenijevic N, Milovanovic M (2020) Galectin-3 in inflammasome activation and primary biliary cholangitis development. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21145097","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10908_CR3","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1111\/jcmm.16500","volume":"25","author":"B Bai","year":"2021","unstructured":"Bai B, Yang Y, Ji S, Wang S, Peng X, Tian C et al (2021) MicroRNA-302c-3p inhibits endothelial cell pyroptosis via directly targeting NOD-, LRR- and pyrin domain-containing protein 3 in atherosclerosis. J Cell Mol Med 25(9):4373\u20134386. https:\/\/doi.org\/10.1111\/jcmm.16500","journal-title":"J Cell Mol Med"},{"issue":"8","key":"10908_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.tips.2023.06.001","volume":"44","author":"S Bouffette","year":"2023","unstructured":"Bouffette S, Botez I, De Ceuninck F (2023) Targeting galectin-3 in inflammatory and fibrotic diseases. Trends PharmacOl Sci 44(8):519\u2013531. https:\/\/doi.org\/10.1016\/j.tips.2023.06.001","journal-title":"Trends PharmacOl Sci"},{"key":"10908_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.764994","volume":"12","author":"RY Cao","year":"2021","unstructured":"Cao RY, Zhang Y, Feng Z, Liu S, Liu Y, Zheng H, Yang J (2021) The effective role of natural product berberine in modulating oxidative stress and inflammation related atherosclerosis: novel insights into the gut-heart axis evidenced by genetic sequencing analysis. Front Pharmacol 12:764994. https:\/\/doi.org\/10.3389\/fphar.2021.764994","journal-title":"Front Pharmacol"},{"issue":"4","key":"10908_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.23736\/s0026-4806.25.09637-5","volume":"116","author":"MR Cesarone","year":"2025","unstructured":"Cesarone MR, Hu S, Belcaro G, Cornelli U, Feragalli B, Corsi M et al (2025) Borderline hyperlipidemia: preventive supplementation with berberine phospholipids to prevent early atherosclerosis evolution. Minerva Med 116(4):285\u2013291. https:\/\/doi.org\/10.23736\/s0026-4806.25.09637-5","journal-title":"Minerva Med"},{"issue":"1","key":"10908_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-023-03780-8","volume":"24","author":"S Chen","year":"2024","unstructured":"Chen S, Xu X, Liu Y, Yao Y, Yang Y, Meng W (2024) Inter-relationships of galectin-3 and NLR family pyrin domain containing 3 inflammasomes with oral lichen planus: a preliminary cross-sectional in vitro study. BMC Oral Health 24(1):14. https:\/\/doi.org\/10.1186\/s12903-023-03780-8","journal-title":"BMC Oral Health"},{"key":"10908_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115261","volume":"293","author":"H Diao","year":"2022","unstructured":"Diao H, Cheng J, Huang X, Huang B, Shao X, Zhao J et al (2022) The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1\/\u03b2-catenin signaling pathway. J Ethnopharmacol 293:115261. https:\/\/doi.org\/10.1016\/j.jep.2022.115261","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"10908_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-016-0584-3","volume":"18","author":"NR Evans","year":"2016","unstructured":"Evans NR, Tarkin JM, Chowdhury MM, Warburton EA, Rudd JH (2016) PET imaging of atherosclerotic disease: advancing plaque assessment from anatomy to pathophysiology. Curr Atheroscler Rep 18(6):30. https:\/\/doi.org\/10.1007\/s11883-016-0584-3","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"10908_CR10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39261","volume":"15","author":"EO Evbayekha","year":"2023","unstructured":"Evbayekha EO, Nwachukwu EU, Nikravesh E, Rosas V, Onuegbu CA, Egwuonwu OF et al (2023) Berberine for adjunct\/alternative treatment of dyslipidemia: a literature review. Cureus 15(5):e39261. https:\/\/doi.org\/10.7759\/cureus.39261","journal-title":"Cureus"},{"issue":"8","key":"10908_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/cvr\/cvae071","volume":"120","author":"S Guo","year":"2024","unstructured":"Guo S, Wang L, Cao K, Li Z, Song M, Huang S et al (2024) Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis. Cardiovasc Res 120(8):883\u2013898. https:\/\/doi.org\/10.1093\/cvr\/cvae071","journal-title":"Cardiovasc Res"},{"key":"10908_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13080532","author":"BG Hsu","year":"2021","unstructured":"Hsu BG, Wang CH, Lai YH, Tsai JP (2021) Serum galectin-3 level is positively associated with endothelial dysfunction in patients with chronic kidney disease stage 3 to 5. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins13080532","journal-title":"Toxins (Basel)"},{"issue":"5","key":"10908_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s11427-022-2189-x","volume":"66","author":"G Hu","year":"2023","unstructured":"Hu G, Wu J, Gu H, Deng X, Xu W, Feng S et al (2023) Galectin-3-centered paracrine network mediates cardiac inflammation and fibrosis upon beta-adrenergic insult. Sci China Life Sci 66(5):1067\u20131078. https:\/\/doi.org\/10.1007\/s11427-022-2189-x","journal-title":"Sci China Life Sci"},{"issue":"6","key":"10908_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/00033197231190513","volume":"75","author":"HL Hu","year":"2024","unstructured":"Hu HL, Wang YY, Jing DT, Zhu F (2024) Galectin-3 as a novel biomarker of predicting prognosis in patients with coronary artery disease. Angiology 75(6):598\u2013599. https:\/\/doi.org\/10.1177\/00033197231190513","journal-title":"Angiology"},{"key":"10908_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.116011","volume":"304","author":"X Jiang","year":"2023","unstructured":"Jiang X, Ma C, Gao Y, Cui H, Zheng Y, Li J et al (2023) Tongxinluo attenuates atherosclerosis by inhibiting ROS\/NLRP3\/caspase-1-mediated endothelial cell pyroptosis. J Ethnopharmacol 304:116011. https:\/\/doi.org\/10.1016\/j.jep.2022.116011","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10908_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/s1474-4422(23)00067-4","volume":"22","author":"PC Lavall\u00e9e","year":"2023","unstructured":"Lavall\u00e9e PC, Charles H, Albers GW, Caplan LR, Donnan GA, Ferro JM et al (2023) Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study. Lancet Neurol 22(4):320\u2013329. https:\/\/doi.org\/10.1016\/s1474-4422(23)00067-4","journal-title":"Lancet Neurol"},{"key":"10908_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.740266","volume":"9","author":"C Li","year":"2021","unstructured":"Li C, Pan J, Xu C, Jin Z, Chen X (2021a) A preliminary inquiry into the potential mechanism of Huang-Lian-Jie-Du decoction in treating rheumatoid arthritis via network pharmacology and molecular docking. Front Cell Dev Biol 9:740266. https:\/\/doi.org\/10.3389\/fcell.2021.740266","journal-title":"Front Cell Dev Biol"},{"key":"10908_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2022.109217","volume":"112","author":"H Li","year":"2023","unstructured":"Li H, Cao Z, Wang L, Li J, Cheng X, Tang Y et al (2023) Chronic high-fat diet induces galectin-3 and TLR4 to activate NLRP3 inflammasome in NASH. J Nutr Biochem 112:109217. https:\/\/doi.org\/10.1016\/j.jnutbio.2022.109217","journal-title":"J Nutr Biochem"},{"issue":"15","key":"10908_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202000746","volume":"65","author":"H Li","year":"2021","unstructured":"Li H, Xiao L, He H, Zeng H, Liu J, Jiang C et al (2021b) Quercetin attenuates atherosclerotic inflammation by inhibiting galectin-3-NLRP3 signaling pathway. Mol Nutr Food Res 65(15):e2000746. https:\/\/doi.org\/10.1002\/mnfr.202000746","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"10908_CR20","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1142\/s0192415x24500381","volume":"52","author":"JN Li","year":"2024","unstructured":"Li JN, Wang MY, Tan YR, Wang LL (2024) Multidirectional intervention of Chinese herbal medicine in the prevention and treatment of atherosclerosis: from endothelial protection to immunomodulation. Am J Chin Med 52(4):925\u2013947. https:\/\/doi.org\/10.1142\/s0192415x24500381","journal-title":"Am J Chin Med"},{"key":"10908_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2023.107255","volume":"154","author":"P Libby","year":"2024","unstructured":"Libby P (2024) Inflammation and the pathogenesis of atherosclerosis. Vascul Pharmacol 154:107255. https:\/\/doi.org\/10.1016\/j.vph.2023.107255","journal-title":"Vascul Pharmacol"},{"key":"10908_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105384","volume":"164","author":"H Liu","year":"2021","unstructured":"Liu H, Zhan X, Xu G, Wang Z, Li R, Wang Y et al (2021) Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases. Pharmacol Res 164:105384. https:\/\/doi.org\/10.1016\/j.phrs.2020.105384","journal-title":"Pharmacol Res"},{"key":"10908_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13091089","author":"L Loffredo","year":"2024","unstructured":"Loffredo L, Carnevale R (2024) Oxidative stress: the hidden catalyst fueling atherosclerosis and cardiovascular disease. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox13091089","journal-title":"Antioxidants (Basel)"},{"key":"10908_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.639558","volume":"12","author":"L Lu","year":"2021","unstructured":"Lu L, Huang J, Xue X, Wang T, Huang Z, Li J (2021) Berberine regulated miR150-5p to inhibit P2X7 receptor, EMMPRIN and MMP-9 expression in oxLDL induced macrophages. Front Pharmacol 12:639558. https:\/\/doi.org\/10.3389\/fphar.2021.639558","journal-title":"Front Pharmacol"},{"key":"10908_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.823387","volume":"10","author":"N Lu","year":"2022","unstructured":"Lu N, Cheng W, Liu D, Liu G, Cui C, Feng C, Wang X (2022) NLRP3-mediated inflammation in atherosclerosis and associated therapeutics. Front Cell Dev Biol 10:823387. https:\/\/doi.org\/10.3389\/fcell.2022.823387","journal-title":"Front Cell Dev Biol"},{"key":"10908_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076426","author":"AM Markin","year":"2023","unstructured":"Markin AM, Markina YV, Bogatyreva AI, Tolstik TV, Chakal DA, Breshenkov DG, Charchyan ER (2023) The role of cytokines in cholesterol accumulation in cells and atherosclerosis progression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24076426","journal-title":"Int J Mol Sci"},{"key":"10908_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.amjcard.2023.06.108","volume":"203","author":"F Mayyas","year":"2023","unstructured":"Mayyas F, Ibrahim K (2023) Evaluating plasma galectin-3 levels in patients with an increased risk of atherosclerotic cardiovascular disease who underwent coronary artery revascularization. Am J Cardiol 203:73\u201380. https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.108","journal-title":"Am J Cardiol"},{"key":"10908_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118864","volume":"277","author":"X Pan","year":"2022","unstructured":"Pan X, Wang H, Zheng Z, Huang X, Yang L, Liu J et al (2022) Pectic polysaccharide from Smilax china L. ameliorated ulcerative colitis by inhibiting the galectin-3\/NLRP3 inflammasome pathway. Carbohydr Polym 277:118864. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118864","journal-title":"Carbohydr Polym"},{"key":"10908_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nu17010127","author":"V Rai","year":"2024","unstructured":"Rai V (2024) High-fat diet, epigenetics, and atherosclerosis: a narrative review. Nutrients. https:\/\/doi.org\/10.3390\/nu17010127","journal-title":"Nutrients"},{"key":"10908_CR30","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.2147\/jir.S276982","volume":"16","author":"VZ Rocha","year":"2023","unstructured":"Rocha VZ, Rached FH, Miname MH (2023) Insights into the Role of Inflammation in the Management of Atherosclerosis. J Inflamm Res 16:2223\u20132239. https:\/\/doi.org\/10.2147\/jir.S276982","journal-title":"J Inflamm Res"},{"key":"10908_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511x-10-8","volume":"10","author":"G Song","year":"2011","unstructured":"Song G, Liu J, Zhao Z, Yu Y, Tian H, Yao S et al (2011) Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet. Lipids Health Dis 10:8. https:\/\/doi.org\/10.1186\/1476-511x-10-8","journal-title":"Lipids Health Dis"},{"key":"10908_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.imlet.2021.03.009","volume":"233","author":"IM Srejovic","year":"2021","unstructured":"Srejovic IM, Lukic ML (2021) Galectin-3 in T cell-mediated immunopathology and autoimmunity. Immunol Lett 233:57\u201367. https:\/\/doi.org\/10.1016\/j.imlet.2021.03.009","journal-title":"Immunol Lett"},{"key":"10908_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.704208","volume":"8","author":"C Sun","year":"2021","unstructured":"Sun C, He B, Sun M, Lv X, Wang F, Chen J et al (2021) Yes-associated protein in atherosclerosis and related complications: a potential therapeutic target that requires further exploration. Front Cardiovasc Med 8:704208. https:\/\/doi.org\/10.3389\/fcvm.2021.704208","journal-title":"Front Cardiovasc Med"},{"key":"10908_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.149560","volume":"1855","author":"Y Sun","year":"2025","unstructured":"Sun Y, Gao SQ, Wang X, Li T, Han YL, Miao SH et al (2025) Galectin-3 activates microglia and promotes neurological impairment via NLRP3\/pyroptosis pathway following traumatic brain injury. Brain Res 1855:149560. https:\/\/doi.org\/10.1016\/j.brainres.2025.149560","journal-title":"Brain Res"},{"key":"10908_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/biom12010046","author":"G Sygitowicz","year":"2021","unstructured":"Sygitowicz G, Maciejak-Jastrzebska A, Sitkiewicz D (2021) The diagnostic and therapeutic potential of galectin-3 in cardiovascular diseases. Biomolecules. https:\/\/doi.org\/10.3390\/biom12010046","journal-title":"Biomolecules"},{"issue":"2","key":"10908_CR36","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/cvr\/cvab010","volume":"118","author":"M Takahashi","year":"2022","unstructured":"Takahashi M (2022) NLRP3 inflammasome as a key driver of vascular disease. Cardiovasc Res 118(2):372\u2013385. https:\/\/doi.org\/10.1093\/cvr\/cvab010","journal-title":"Cardiovasc Res"},{"key":"10908_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098162","author":"DM Tanase","year":"2023","unstructured":"Tanase DM, Valasciuc E, Gosav EM, Ouatu A, Buliga-Finis ON, Floria M et al (2023) Portrayal of NLRP3 inflammasome in atherosclerosis: current knowledge and therapeutic targets. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24098162","journal-title":"Int J Mol Sci"},{"key":"10908_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115200","volume":"165","author":"JM Wei","year":"2023","unstructured":"Wei JM, Yuan H, Liu CX, Wang ZY, Shi M, Guo ZH, Li Y (2023) The Chinese medicine Xin-tong-tai granule protects atherosclerosis by regulating oxidative stress through NOX\/ROS\/NF-\u03baB signal pathway. Biomed Pharmacother 165:115200. https:\/\/doi.org\/10.1016\/j.biopha.2023.115200","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10908_CR39","doi-asserted-by":"publisher","first-page":"10924","DOI":"10.1080\/21655979.2021.1995994","volume":"12","author":"S Xu","year":"2021","unstructured":"Xu S, Wu B, Zhong B, Lin L, Ding Y, Jin X et al (2021) Naringenin alleviates myocardial ischemia\/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) \/System xc-\/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered 12(2):10924\u201310934. https:\/\/doi.org\/10.1080\/21655979.2021.1995994","journal-title":"Bioengineered"},{"key":"10908_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116304","volume":"309","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wang Z, Li X, Chen J, Yu Z, Li X et al (2023) Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome. J Ethnopharmacol 309:116304. https:\/\/doi.org\/10.1016\/j.jep.2023.116304","journal-title":"J Ethnopharmacol"},{"key":"10908_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115749","volume":"301","author":"W Zhi","year":"2023","unstructured":"Zhi W, Liu Y, Wang X, Zhang H (2023) Recent advances of traditional Chinese medicine for the prevention and treatment of atherosclerosis. J Ethnopharmacol 301:115749. https:\/\/doi.org\/10.1016\/j.jep.2022.115749","journal-title":"J Ethnopharmacol"},{"key":"10908_CR42","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5621","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Hu Z, Liu J, Duan H, Zeng J, Li X et al (2025) Epigenetic\u2011ncRNA crosstalk in atherosclerosis: mechanisms, disease progression and therapeutic potential (review). Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2025.5621","journal-title":"Int J Mol Med"},{"key":"10908_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2022.09.018","volume":"101","author":"D Zong","year":"2023","unstructured":"Zong D, Liu X, Shen C, Liu T, Ouyang R (2023) Involvement of galectin-3 in neurocognitive impairment in obstructive sleep apnea via regulating inflammation and oxidative stress through NLRP3. Sleep Med 101:1\u201310. https:\/\/doi.org\/10.1016\/j.sleep.2022.09.018","journal-title":"Sleep Med"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10908-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10908-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10908-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:19:41Z","timestamp":1792271981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10908-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10908"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10908-x","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was reviewed and approved by the Animal Ethics Committee of Hubei University of Traditional Chinese Medicine, and the reporting of this research complies with the ARRIVE guidelines.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"264"}}